These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15308358)

  • 1. Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis).
    Turnbull PC; Tindall BW; Coetzee JD; Conradie CM; Bull RL; Lindeque PM; Huebschle OJ
    Vaccine; 2004 Sep; 22(25-26):3340-7. PubMed ID: 15308358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally acquired anthrax antibodies in a cheetah (Acinonyx jubatus) in Botswana.
    Good KM; Houser A; Arntzen L; Turnbull PC
    J Wildl Dis; 2008 Jul; 44(3):721-3. PubMed ID: 18689661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine.
    Phaswana PH; Ndumnego OC; Koehler SM; Beyer W; Crafford JE; van Heerden H
    Vet Res; 2017 Sep; 48(1):46. PubMed ID: 28882176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.
    Hewetson JF; Little SF; Ivins BE; Johnson WM; Pittman PR; Brown JE; Norris SL; Nielsen CJ
    Vaccine; 2008 Aug; 26(33):4262-6. PubMed ID: 18586363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
    Little SF; Ivins BE; Webster WM; Fellows PF; Pitt ML; Norris SL; Andrews GP
    Vaccine; 2006 Mar; 24(14):2530-6. PubMed ID: 16417950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
    Lininger LA; Cullum ME; Lyles MB; Bienek DR
    Vaccine; 2007 Feb; 25(9):1619-25. PubMed ID: 17150286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in maternal immunity and antibody response to vaccine in captive cheetah (Acinonyx jubatus) cubs.
    Spencer JA; Burroughs R
    J Wildl Dis; 1992 Jan; 28(1):102-4. PubMed ID: 1312644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.
    Mikszta JA; Sullivan VJ; Dean C; Waterston AM; Alarcon JB; Dekker JP; Brittingham JM; Huang J; Hwang CR; Ferriter M; Jiang G; Mar K; Saikh KU; Stiles BG; Roy CJ; Ulrich RG; Harvey NG
    J Infect Dis; 2005 Jan; 191(2):278-88. PubMed ID: 15609239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109.
    Gu M; Hine PM; James Jackson W; Giri L; Nabors GS
    Vaccine; 2007 Jan; 25(3):526-34. PubMed ID: 16973247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A; Midha S; Bhatnagar R
    Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
    Flick-Smith HC; Waters EL; Walker NJ; Miller J; Stagg AJ; Green M; Williamson ED
    Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.